Truecaller, the global communications leader in caller identification and spam blocking with 450 million active users worldwide, today announced the launch of its comprehensive Advertising ...

Oncocytomas, oncocytic neoplasms of low malignant potential, and lower-stage chromophobe RCC do not recur with prolonged follow-up.

The predictive analytics market within the banking sector has been witnessing substantial growth in recent years, fueled by the increasing adoption of data-driven decision-making processes and the ...

Alongside Leah Blankenship and Lila Kaye, two neurodivergent graduate students from UO, Smear created the NeuroDiversity Innovation Centers for Excellence in Neuroscience, otherwise known as “NICE in ...

In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...

Despite no difference in event-free survival found between short and long preoperative chemo, long preoperative significantly increased CA19-9 response rate, N0 resection rate, number of the ...

The TRM takes a different approach. Jolicoeur-Martineau was inspired by a technique known as the hierarchical reasoning model ...

Truecaller, the caller identification and spam blocking platform with 450 million active users worldwide, today announced the ...

More than a quarter of patients with renal cell carcinoma on active surveillance experience spontaneous tumor regression, researchers report.

Yoshua Bengio talks about his efforts to identify — and address — the risks posed by AI.

Extremely preterm infants with higher fat-free mass at term-equivalent age show better cognitive, language, and motor ...

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...